Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 USD | 0.00% | +13.33% | -94.37% |
04-15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- News Acorda Therapeutics, Inc.
- Acorda Therapeutics : Signs Deal With Esteve Pharmaceuticals for Commercialization of Inbrija in Spain; Shares Jump